Paulson Richard A.

President And CEO

1 company

Excellent

Trades Analyzed

12M Win Rate

92.5%

Avg 3M Return

+16.9%

Avg 12M Return

+47.6%

Paulson Richard A. is a President And CEO at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $1.7M based on current market prices.

Holdings by Company

KPTIOct 15, 2025

Current Shares198.3K

Value$1.71M

Net Activity-292,024

Bought: 0Sold: 292.0K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 6, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,608	$0.93	$3,355.08	-0.3%	+11.1%	-68.0%
Jul 5, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,616	$0.85	$3,077.22	-0.3%	+7.6%	-65.6%
Jun 4, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,592	$0.99	$3,556.08	-0.3%	-22.3%	-68.8%
May 6, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,576	$1.13	$4,040.88	-0.3%	-24.3%	-63.7%
Apr 4, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,563	$1.29	$4,596.27	-0.3%	-37.7%	-80.7%
Mar 5, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,573	$1.30	$4,644.90	-0.3%	-20.7%	-67.2%
Mar 1, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	99,844	$1.18	$117,398.70	-4.1%	-20.0%	-55.3%
Feb 6, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	4,012	$1.59	$6,365.04	-0.5%	-30.7%	-59.5%
Jan 4, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	4,114	$0.82	$3,373.48	-0.5%	+55.8%	-5.5%
Dec 4, 2023	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,622	$0.79	$2,861.38	-0.5%	+49.7%	-7.4%